<< History of AIDS last
page
2000-2004: The Elusive Quest for an HIV Vaccine
According to the International AIDS Vaccine Initiative, "Only an AIDS vaccine
can end the HIV/AIDS pandemic." With AIDS killing worldwide more people than
any other infectious disease, 40 million people are living with the disease, and
nearly all those will die within the next twenty years. 95% of all new infections
occur in developing countries. Prevention has slowed the spread, but not arrested
it. Treatment programs are costly and complex in the short term, and subject to side
effects and viral resistance in the long term. If smallpox was eradicated in 1977
with an effective vaccine, then "an AIDS vaccine is possible." "Developing
an AIDS vaccine to save lives and economies will be one of the world's greatest achievements."
Source: International
AIDS Vaccine Initiative With HIV's spread showing no
signs of slowing -- 5 million people were newly infected in 2003 with 14,000 new
infections daily or 600 new infections hourly -- the need for an HIV vaccine may
even be greater, since in 2003, "almost five million people became infected
with HIV, the greatest number of infections in a given year since the beginning of
the epidemic." Source: International AIDS Vaccine Initiative As
recent as February 24, 2003, VaxGen, Inc. "announced initial results from the
first of its three-year, multi-national, randomized, double-blind, placebo-controlled
Phase III trials of AIDSVAX (rgp120) to prevent HIV infection. The study did not
show a statistically significant reduction of HIV infection within the study population
as a whole, which was the primary endpoint of the trial." Source: VaxGen, Inc. The failure of VaxGen's vaccine trial was consistent with the failure of
every other attempt thus far, and it had been the "world's most advanced human
vaccine experiment." Before the end of 2003, the testing of another HIV vaccine
would begin in South Africa, where 10% of the population is infected with HIV. Source:
Wired News South Africa suffers from a
death rate of about 600 to 1,000 people a day from AIDS related complications; and,
it is where South African President Thabo Mbeki publicly questioned the safety of
anti-AIDS drugs and whether HIV was the cause of AIDS at the 13th International AIDS
Conference in Durban, South Africa on July 9, 2000. Source: CNN According to a November 3, 2003 CNN
account, "Human HIV vaccine trial begins," the South African testing of
an experimental HIV vaccine would contain for the first time, "genetic material
from the HIV strain most prevalent in South Africa." At the time of that writing,
about two dozen other HIV vaccine experiments were being conducted; but, no previous
trials had ever proved successful. Tim Tucker, head of the South African AIDS Vaccine
Initiative, predicted that even if successful, "it would be at least ten years
before an effective vaccine was ready for distribution." Source: Wired
News
2005: Using Bacteria to Protect Against HIV
In Wired News, an article "Anti-HIV Bacterium Isolated?" by Rowan
Hooper was posted 02:00 AM Apr. 20, 2005 PT, suggesting that hope for an answer to
HIV infection may be nearer. Researcher Lin Tao from the University of Illinois at
Chicago's dentistry college and colleagues
from Rush University have discovered a strain of lactobacillus, that
"binds to the sugar envelope on the surface of HIV," thus targeting HIV
"because it uses the sugar as a food source." Why is this important? Two
strains of this harmless bacterium, found in the oral and vaginal cavities of healthy
human volunteers, trap the HIV virus by eating mannose (a sugar) and blocking infection
-- at least, in the lab, so far. Tao explains, "If we can find its natural enemy,
we can control the spread of HIV naturally and cost-effectively, just as we use cats
to control mice." Since Tao's work has not been tested outside of the laboratory,
the HIV research community has refrained from premature celebration. Tao is using
the concept of probiotic foods, e.g., foods such as yogurt which contain beneficial
bacteria, to deal with the even more serious infection of HIV. From oral hygiene,
we know that cavities or dental caries are caused by bacteria normally present in
our mouth converting the sugar and starch left upon our teeth into enamel dissolving
acid beginning within 20 minutes after the last meal or snack, so we brush our teeth,
use an antiseptic mouth rinse, and floss to deprive the bacteria of their meal, and
thus aid in the prevention of cavities. Using this principle of bacteria's attraction
to sugar, Tao said, "Different bacteria have different sugar preferences. To
block HIV, however, we needed to find bacteria that prefer the unusual sugar mannose
and thus can capture it." Clinical trials are planned. Journalist Rowan Hooper
points out in this article that: (1) This HIV-capturing lactobacillus is welcome,
though an HIV vaccine would be better, (2) "It would be safe and easy to use,"
(3) An anti-HIV bacterium would provide "broad spectrum" protection against
all subtypes of HIV (unlike a vaccine), (4) It could protect infants from contracting
HIV from breast milk, (5) It could protect women against sexual transmission of HIV,
despite a failure to use a condom, and (6) Possibly, most important of all, an HIV-capturing
bacterium would be relatively inexpensive to develop, i.e., "The developmental
cost for a vaccine is about $100 million to $1 billion," said Tao, "but
a probiotic may only cost a few million." Source: Wired News
<< History of
AIDS last page || Back to Homepage >>
The History of AIDS © 2005
Legal Disclaimer: "The History of AIDS" is not affiliated
in any way with the organizations, or third party links found at this website, with
the exception of links to Amazon.com. The information at this website should not
be taken as medical advice, treatment, or diagnosis, express or implied. Even though
a reasonable effort has been made to present correct information, no warranty is
made that the data at this website is true or accurate. Consult your health care
professional before beginning ANY treatment or regimen.
Member of Fohn.net
|